These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 22316568)

  • 1. Negative symptoms have greater impact on functioning than positive symptoms in schizophrenia: analysis of CATIE data.
    Rabinowitz J; Levine SZ; Garibaldi G; Bugarski-Kirola D; Berardo CG; Kapur S
    Schizophr Res; 2012 May; 137(1-3):147-50. PubMed ID: 22316568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical determinants of life satisfaction in chronic schizophrenia: data from the CATIE study.
    Fervaha G; Agid O; Takeuchi H; Foussias G; Remington G
    Schizophr Res; 2013 Dec; 151(1-3):203-8. PubMed ID: 24183751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responses to antipsychotic therapy among patients with schizophrenia or schizoaffective disorder and either predominant or prominent negative symptoms.
    Stauffer VL; Song G; Kinon BJ; Ascher-Svanum H; Chen L; Feldman PD; Conley RR
    Schizophr Res; 2012 Feb; 134(2-3):195-201. PubMed ID: 22019076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of prominent positive and prominent negative symptoms and functional health, well-being, healthcare-related quality of life and family burden: a CATIE analysis.
    Rabinowitz J; Berardo CG; Bugarski-Kirola D; Marder S
    Schizophr Res; 2013 Nov; 150(2-3):339-42. PubMed ID: 23899997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender-specific associations of depression with positive and negative symptoms in acute schizophrenia.
    Müller MJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1095-100. PubMed ID: 17493732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study.
    Bobes J; Arango C; Garcia-Garcia M; Rejas J;
    J Clin Psychiatry; 2010 Mar; 71(3):280-6. PubMed ID: 19895779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restrictive symptomatic inclusion criteria create barriers to clinical research in schizophrenia negative symptoms: an analysis of the CATIE dataset.
    Dunayevich E; Chen CY; Marder SR; Rabinowitz J
    Eur Neuropsychopharmacol; 2014 Oct; 24(10):1615-21. PubMed ID: 25172269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative contribution of antipsychotics, negative symptoms and executive functions to social functioning in stable schizophrenia.
    Rocca P; Montemagni C; Castagna F; Giugiario M; Scalese M; Bogetto F
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):373-9. PubMed ID: 19211031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of antipsychotic medication on overall life satisfaction among individuals with chronic schizophrenia: findings from the NIMH CATIE study.
    Fervaha G; Agid O; Takeuchi H; Foussias G; Remington G
    Eur Neuropsychopharmacol; 2014 Jul; 24(7):1078-85. PubMed ID: 24726579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of different aspects of everyday outcome in schizophrenia: The roles of negative symptoms, cognition, and functional capacity.
    Strassnig MT; Raykov T; O'Gorman C; Bowie CR; Sabbag S; Durand D; Patterson TL; Pinkham A; Penn DL; Harvey PD
    Schizophr Res; 2015 Jun; 165(1):76-82. PubMed ID: 25868935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of aripiprazole versus haloperidol on PANSS Prosocial items in early-episode patients with schizophrenia.
    Docherty JP; Baker RA; Eudicone J; Mathew S; Marcus RN; McQuade RD; Mankoski R
    Schizophr Res; 2010 Jul; 120(1-3):199-203. PubMed ID: 20547037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The selective glycine uptake inhibitor org 25935 as an adjunctive treatment to atypical antipsychotics in predominant persistent negative symptoms of schizophrenia: results from the GIANT trial.
    Schoemaker JH; Jansen WT; Schipper J; Szegedi A
    J Clin Psychopharmacol; 2014 Apr; 34(2):190-8. PubMed ID: 24525661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of augmentation with moclobemide on symptoms of schizophrenia.
    Silver H; Aharon N; Hausfater N; Jahjah N
    Int Clin Psychopharmacol; 1999 May; 14(3):193-5. PubMed ID: 10435775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abbreviated quality of life scales for schizophrenia: comparison and utility of two brief community functioning measures.
    Fervaha G; Foussias G; Siddiqui I; Agid O; Remington G
    Schizophr Res; 2014 Apr; 154(1-3):89-92. PubMed ID: 24630140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Quality of life in patients with schizophrenia: a study of 100 cases].
    Zouari L; Thabet JB; Elloumi Z; Elleuch M; Zouari N; Maâlej M
    Encephale; 2012 Apr; 38(2):111-7. PubMed ID: 22516268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized trial to evaluate the efficacy of cognitive therapy for low-functioning patients with schizophrenia.
    Grant PM; Huh GA; Perivoliotis D; Stolar NM; Beck AT
    Arch Gen Psychiatry; 2012 Feb; 69(2):121-7. PubMed ID: 21969420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of cognition and psychopathology to functional impairment in schizophrenia.
    Mohamed S; Rosenheck R; Swartz M; Stroup S; Lieberman JA; Keefe RS
    Am J Psychiatry; 2008 Aug; 165(8):978-87. PubMed ID: 18450928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal prediction error is associated with negative and depressive symptoms in schizophrenia.
    Moran PM; Owen L; Crookes AE; Al-Uzri MM; Reveley MA
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):116-23. PubMed ID: 17764799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extent of attaining and maintaining symptom remission by antipsychotic medication in the treatment of chronic schizophrenia: evidence from the CATIE study.
    Levine SZ; Rabinowitz J; Ascher-Svanum H; Faries DE; Lawson AH
    Schizophr Res; 2011 Dec; 133(1-3):42-6. PubMed ID: 22000938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of depression and negative symptoms in schizophrenia.
    Goldman RS; Tandon R; Liberzon I; Greden JF
    Psychopathology; 1992; 25(1):49-56. PubMed ID: 1351305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.